BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
55 hedge funds and large institutions have $300M invested in Bellicum Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 55 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+55
Holders Change %
–
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
55
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$98.7M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$33.9M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$24.1M |
| 4 |
RG
4
Redmile Group
San Francisco,
California
|
$17.3M |
| 5 |
5
Jennison Associates
New York
|
$16.8M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FMA
51
FNY Managed Accounts
New York
| $92.2K | +$92.2K | +400 | New |
|
|
CSS
52
Cubist Systematic Strategies
Stamford,
Connecticut
| $28K | +$28K | +120 | New |
|
|
AIG
53
American International Group
New York
| $23K | +$23K | +100 | New |
|
|
SM
54
Sabby Management
Miami Beach,
Florida
| $7.64K | +$7.64K | +33,152 | New |
|
55
Bank of America
Charlotte,
North Carolina
| $2K | +$2K | +10 | New |
|